Tilray Brands Inc (TLRY)
1.74
+0.02
(+1.16%)
USD |
NASDAQ |
Apr 19, 11:38
Tilray Brands Revenue (Quarterly): 188.34M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 188.34M |
| November 30, 2023 | 193.77M |
| August 31, 2023 | 176.95M |
| May 31, 2023 | 184.19M |
| February 28, 2023 | 145.59M |
| November 30, 2022 | 144.14M |
| August 31, 2022 | 153.21M |
| May 31, 2022 | 153.32M |
| February 28, 2022 | 151.87M |
| November 30, 2021 | 155.15M |
| August 31, 2021 | 168.02M |
| May 31, 2021 | 142.24M |
| February 28, 2021 | 123.90M |
| November 30, 2020 | 129.46M |
| August 31, 2020 | 117.49M |
| May 31, 2020 | 113.37M |
| February 29, 2020 | 107.80M |
| November 30, 2019 | 90.75M |
| August 31, 2019 | 94.36M |
| Date | Value |
|---|---|
| May 31, 2019 | 96.74M |
| February 28, 2019 | 55.97M |
| November 30, 2018 | 16.32M |
| August 31, 2018 | 10.23M |
| May 31, 2018 | 9.145M |
| February 28, 2018 | 8.037M |
| November 30, 2017 | 6.608M |
| August 31, 2017 | 4.848M |
| May 31, 2017 | 4.011M |
| February 28, 2017 | 3.881M |
| November 30, 2016 | 3.890M |
| August 31, 2016 | 3.342M |
| May 31, 2016 | 2.291M |
| February 29, 2016 | 1.978M |
| November 30, 2015 | 1.516M |
| August 31, 2015 | 0.718M |
| May 31, 2015 | 0.4025M |
| February 28, 2015 | 0.0412M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
90.75M
Minimum
Nov 2019
193.77M
Maximum
Nov 2023
141.53M
Average
144.86M
Median
Revenue (Quarterly) Benchmarks
| Clever Leaves Holdings Inc | 4.638M |
| Flora Growth Corp | 17.98M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 45.10M |
| Edesa Biotech Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -92.70M |
| Total Expenses (Quarterly) | 221.71M |
| EPS Diluted (Quarterly) | -0.12 |
| Enterprise Value | 1.493B |
| Gross Profit Margin (Quarterly) | 26.23% |
| Profit Margin (Quarterly) | -49.22% |
| Earnings Yield | -25.29% |
| Normalized Earnings Yield | -30.25 |